headerphoto

Welcome to the inaugural edition of CFForward

We are very excited to announce the launch of the Cystic Fibrosis Foundation, Greater New York Chapter’s quarterly e-newsletter! Four times a year, we will deliver CF-related news to you straight from CFF staff, volunteers, and the community.

As we kick start our first issue, we are thrilled to share that the Foundation officially unveiled its new visual identity and logo in July. The new mark bears the words, adding tomorrows – the organization’s tagline – and features the image of a rising sun, symbolizing past progress and hope for the future for all people with the disease.

The new logo, which is only the second in the Foundation’s history, captures the spirit of forward momentum in the fight against the disease. Through its successful “venture philanthropy” model, the Foundation has raised and invested hundreds of millions of dollars in promising CF research and a robust pipeline of potential therapies that target the disease from every angle. Nearly every CF drug available today was made possible because of the Foundation’s support and ongoing work with researchers and the pharmaceutical industry to find a cure.

The new visual identity launched during a landmark year of progress in treating cystic fibrosis. This includes the January 2012 U.S. Food and Drug Administration approval of Kalydeco™, the first drug to address the underlying cause of the disease for 4% of the CF population.